Welcome to our dedicated page for KKR & Co. news (Ticker: KKR), a resource for investors and traders seeking the latest updates and insights on KKR & Co. stock.
KKR & Co. Inc. (NYSE: KKR), founded in 1976 by Henry Kravis and George Roberts, is a leading global investment firm managing investments across various asset classes such as private equity, energy, infrastructure, real estate, credit, and hedge funds. Headquartered in New York, KKR aims to generate attractive investment returns through a patient and disciplined investment approach, employing world-class talent, and driving growth and value creation at the asset level.
As of March 2023, KKR boasts an impressive $577.6 billion in total managed assets, which includes $470.6 billion in fee-earning assets under management (AUM). KKR operates through two primary segments: Asset Management and Insurance. The Asset Management segment involves private markets (private equity, credit, infrastructure, energy, and real estate) and public markets (primarily credit and hedge/investment fund platforms). The Insurance segment follows KKR's acquisition of Global Atlantic Financial Group, focusing on retirement, annuity, life insurance, and reinsurance products.
KKR invests its own capital alongside its partners' capital, offering opportunities through its capital markets business. The firm's commitment to excellence and growth is evident in its strategic partnerships and significant investments, such as its recent venture with Capital Group to introduce hybrid public-private market investment solutions designed to provide broader access to alternative investments.
In recent news, KKR announced significant developments, including a strategic partnership with Capital Group and a $600 million cash acquisition of Mirus Bio by Gamma Biosciences, a life sciences platform established by KKR.
- Latest News: FS KKR Capital Corp. declared a second-quarter 2024 distribution of $0.75 per share.
- Strategic Partnerships: KKR and Capital Group join forces to create hybrid public-private market investment solutions.
- Acquisitions: Gamma Biosciences, backed by KKR, agreed to sell Mirus Bio to Merck KGaA for $600 million.
For more information, visit KKR's website or follow them on Twitter: @kkr_co.
KKR has appointed Tim Lawler as an Executive Advisor, enhancing its talent management capabilities within the health care sector. Mr. Lawler, a seasoned private equity professional with over 20 years of experience, will collaborate with the KKR Americas Health Care team to build long-lasting relationships with top executives. His track record includes leadership roles at Waud Capital Partners and Highland Capital Management. KKR has invested approximately $19 billion in health care over the last 25 years, and Lawler aims to further attract high-caliber talent to the firm, positioning KKR as a premier partner for health care leaders.
The Board of Trustees of KKR Income Opportunities Fund (NYSE: KIO) has approved a Rights Offering for shareholders to subscribe for additional shares, with a record date set for
KKR has announced a further $1.15 billion investment to expand its portfolio of leased commercial aircraft in partnership with Altavair, bringing total commitments to $1.7 billion since 2018. This expansion will enhance their ability to support the fleet needs of airlines globally, as demand for aircraft leasing grows. KKR's aviation investments since 2015 have reached approximately $8.3 billion. The partnership has successfully acquired over 90 aircraft, with 75% leased to tier-one airlines.
KKR has announced a new investment in South Korean energy company SK E&S, acquiring newly issued redeemable convertible preferred shares (RCPS). This marks KKR's second investment in SK E&S since November 2021, aimed at supporting the company’s transformation into a global clean energy solutions provider. SK E&S plans to utilize this capital to improve liquidity and capture post-pandemic opportunities in the energy sector. With over US$15 billion in global investments in renewables since 2011, KKR underlines its commitment to the clean energy market.
KKR has reported a strong monetization activity update for the period from
KKR has signed definitive agreements to acquire all shares of Bushu Pharmaceuticals from BPEA EQT. This strategic move aims to enhance Bushu Pharma's growth as a leading contract development and manufacturing organization (CDMO) in Japan and globally. Founded in 1998, Bushu Pharma specializes in producing high-quality pharmaceuticals, including oral solid dosages and injectables. KKR plans to work with Bushu Pharma’s management to expand into new segments, invest in capacity, and improve quality control. The transaction is expected to finalize in Q1 2023, pending approvals.
KKR has released its 2023 Global Macro Outlook, authored by CIO Henry McVey, emphasizing a simpler investment strategy amidst ongoing inflation concerns. Key insights include expectations of earnings declines in 2023 with only modest recovery in 2024, persistent labor shortages, and pressure on U.S. housing prices. The report advocates for investments in real assets and simple credit, citing a structural labor market issue and shifting inflation dynamics. The outlook suggests a selective approach to investments over the next 12 to 18 months.
KKR Real Estate Select Trust Inc. (KREST) has acquired a portfolio of 39 newly built multifamily properties in Tokyo, Japan. This investment, part of KREST’s stabilized real estate strategy, is expected to generate stable cash flows due to a master lease with a leading property manager ensuring 100% occupancy. With KKR managing approximately US$64 billion in assets globally, this acquisition highlights KREST's focus on high-quality, income-producing real estate in a strong market. KREST aims for attractive current income and long-term capital appreciation.
KKR has released a new macro report titled Regime Change: The Benefits of Private Credit in the ‘Traditional’ Portfolio, emphasizing a shift in portfolio construction strategies. The report suggests reallocating from traditional 60/40 models to a more diversified 40/30/30 structure that includes Private Credit, Infrastructure, and Real Estate. Factors such as the pullback of traditional lenders and improved lending terms make Private Credit an attractive option for investors. The report calls for a rethinking of asset allocation approaches in this evolving economic landscape.
Mediawan, a European content studio, is acquiring a significant stake in Plan B Entertainment, co-founded by Brad Pitt. This partnership aims to expand Mediawan's reach into the U.S. market and enhance global content production across film and television. The acquisition aligns with Mediawan's strategy to facilitate international projects and foster talent development. The financial details remain undisclosed, but the deal is backed by Mediawan's investors, including KKR and Atwater Capital. Both companies aim to leverage their expertise to create a unique artistic link between Europe and the U.S.
FAQ
What is the current stock price of KKR & Co. (KKR)?
What is the market cap of KKR & Co. (KKR)?
What does KKR & Co. Inc. do?
Who founded KKR & Co. Inc.?
What are the main business segments of KKR?
How much are KKR's total managed assets?
What recent strategic partnerships has KKR announced?
What recent acquisitions has KKR been involved in?
Where can I find more information about KKR & Co. Inc.?
What is KKR’s approach to investments?
How can I stay updated with KKR’s news?